Improving life after brain injury Need to talk? 0808 800 2244

Join
Home About brain injury Further information Research Neuroendocrine dysfunction

Hypopituitarism [seminar]

Hypopituitarism [seminar] Main Image

Hypopituitarism [seminar]

Sat 28 Apr 2007

Work has shown that many patients with brain damage are at high risk of (sometimes unrecognised) hypopituitarism.

Summary

Incidence and prevalence of hypopituitarism are estimated to be 4-2 per 100 000 per year and 45-5 per 100 000, respectively. Although the clinical symptoms of this disorder are usually unspecific, it can cause life-threatening events and lead to increased mortality. Current research has refined the diagnosis of hypopituitarism. Identification of growth hormone and corticotropin deficiency generally requires a stimulation test, whereas other deficiencies can be detected by basal hormones in combination with clinical judgment. Newly developed formulations of replacement hormones are convenient and physiological. Work has shown that many patients with brain damage -- such as traumatic brain injury or aneurysmal subarachnoid haemorrhage -- are at high risk of (sometimes unrecognised) hypopituitarism. Thus, a much increased true prevalence of this disorder needs to be assumed. As a result, hypopituitarism is not a rare disease and should be recognised by the general practitioner.


Reference

Schneider, HJ., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G-K. and Ghigo, E. (2007) Hypopituitarism [seminar]. Lancet 369:1461-70.

Back

Share this page

Headway - the brain injury association is registered with the Charity Commission for England and Wales (Charity no. 1025852) and the Office of the Scottish Regulator (Charity no. SC 039992). Headway is a company limited by guarantee, registered in England no. 2346893.

© Copyright Headway 2019  -  Site designed and developed by MEDIAmaker